EP12.02. Treatment Patterns and Economic Burden of Brain Metastases (BM) in Patients with ALK+ mNSCLC Receiving ALK TKIs - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Hannah Le
Meta Tag
Speaker Hannah Le
Topic Metastatic NSCLC: Targeted Therapy - FUSIONS
brain metastases
ALK non-small cell lung cancer
tyrosine kinase inhibitors
retrospective analysis
treatment patterns
economic burden
medical costs
systemic therapy
BM occurrence
first-line setting
Powered By